Pharmacological inhibition of the NLRP3 inflammasome as a potential target for cancer-induced bone pain
Shuping Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yuke Tian(Tongji Hospital), Xiaomei Wang(Shanghai University of Traditional Chinese Medicine), Ya‐Qun Zhou(Tongji Hospital), Jia Sun(Union Hospital), Fei Cao(Tongji Hospital), Dawei Ye(Tongji Hospital)
Cited by 100
Related Papers
Interleukin-6: an emerging regulator of pathological pain
|Journal of Neuroinflammation|2016|438
Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts
|The Journal of Experimental Medicine|2006|353
Carbon Monoxide and Its Controlled Release: Therapeutic Application, Detection, and Development of Carbon Monoxide Releasing Molecules (CORMs)
|Journal of Medicinal Chemistry|2017|316
Targeting JAK-STAT Signaling to Control Cytokine Release Syndrome in COVID-19
|Trends in Pharmacological Sciences|2020|304
Development and Validation of a Nomogram for Assessing Survival in Patients With COVID-19 Pneumonia
|Clinical Infectious Diseases|2020|138